Daily as of 3 Nov 16:00 ET
- Price
- below both $18.54 vs 50 $19.24 / 200 $18.70
- Projection
- 💀Death cross estimated in 17 to 24 bars
- Test
- No active test
- Last cross
- 🟨Golden cross 9 Oct 2026 · projected 28 bars out · tested 1 bar
SRPT | Sarepta TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$18.54
+$0.22 (+1.20%)
Sarepta Therapeutics (SRPT) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Oct 2026, and the two have been drifting apart, yet a death cross is projected within 30 bars. On both the daily and the weekly, price sits below the 50 and the 200; on the 4-hour it is above both.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- below both $18.62 vs 50 $19.04 / 200 $79.93
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross week of 9 Jun 2025 · projected 28 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- above both $18.54 vs 50 $17.97 / 200 $18.28
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 26 Oct 2026 bar 1 · projected 26 bars out · tested 2 bars
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 26 Oct 2026 | 💀Death | 4-hour | 26 bars out | 2 bar cross test |
| 9 Oct 2026 | 🟨Golden flat | daily | 28 bars out | 1 bar cross test |
| 2 Sep 2026 | 🟨Golden | 4-hour | 26 bars out | Not tested |
| 8 Jun 2026 | 💀Death flat | daily | 29 bars out | Not tested |
| 22 May 2026 | 💀Death | 4-hour | 21 bars out | Not tested |
About SRPT
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$46.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandmid